Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01643018
Other study ID # MK-001-CH
Secondary ID
Status Completed
Phase N/A
First received June 26, 2012
Last updated July 16, 2012
Start date November 2006
Est. completion date May 2012

Study information

Verified date July 2012
Source Medical Park Gaziantep Hospital
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

Echinococcosis in humans is a parasitic tapeworm infection, caused by a larval stage (the metacestode) of Echinococcus species. The infection can be asymptomatic or severe, causing extensive organ damage and even death of the patient.

Echinococcosis is one of the most neglected parasitic diseases and the lack of the prospective randomised studies supports this idea. Development of new drugs and other treatment modalities receives very little attention, if any. In most developed countries, Cystic Echinococcosis (CE) is an imported disease of very low incidence and prevalence and is found almost exclusively in migrants from endemic regions. In endemic regions, predominantly settings with limited resources, patient numbers are high.

The aim of the hydatid cyst treatment is the death of the parasite and consequently the cure of the disease. It has to be done with a minimal risk and maximum comfort for the patient, and always paying attention to avoid complications, secondary hydatidosis, and relapses.

There are several treatment modalities. Of them the most preferred surgical method is traditional cyst management through a laparotomy incision. Same can be done with laparoscopy. In the past 15 years significant advances in laparoscopic surgical skills and techniques combined with explosive advances in laparoscopic technology have encouraged the application of laparoscopy to the evaluation and treatment of solid organs including the liver. There are many studies about the laparoscopic treatment of liver hydatid cyst published in the literature and the feasibility of this procedure has been demonstrated by them. While the majority of them are case reports or case series, there are some relatively large series comparing open versus laparoscopic surgery published in the last decade, which all are not randomized trial.


Description:

This is a multicenter, balanced randomization, double blind, active-controlled, parallel-group, non-inferiority study conducted in Turkey (4 sites).

The objective of this trial is to show there is no difference in rate of recurrence 2 years after laparoscopic as compared to open management of cystic echinococcosis of the liver, by at least M (non-inferiority margin). If PLAP/POP: denotes the cure rate in the laparoscopy group (LAP) / open group (OP), then the following two-sided test problem is assessed:

H0: POP − PLAP >= M (Open Surgery is superior to Laparoscopic surgery) H1: POP − PLAP < M (Laparoscopic surgery is not inferior to open surgery)


Recruitment information / eligibility

Status Completed
Enrollment 350
Est. completion date May 2012
Est. primary completion date November 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- patients eighteen year-old or older

- patients diagnosed as cystic echinococcosis of the liver

- cyst number less then 3

- cyst size greater than 3 cm

Exclusion Criteria:

- previous liver surgery

- recurrent disease

- hydatid cyst with multi-organ involvement

- liver hydatid cyst complicated with infection

- contraindication for general anesthesia

- contraindication for laparoscopic surgery

- patient younger than 18

- allergy to albendazole

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
laparoscopic surgery
In laparoscopy group three trocars is used. The first is 10 mm and inserted within the umbilicus for telescop, the second is 10 mm and inserted just below the xiphoid process, and third is 5 mm and inserted at the right upper quadrant of the abdomen.
open surgery
-open surgery group describes the patients treated with traditional open surgery. In open surgery group a right subcostal incision is used.

Locations

Country Name City State
Turkey 25 Aralik State Hospital Gaziantep
Turkey Dr.Ersin Aslan State Hospital Gaziantep
Turkey Hatem Hospital Gaziantep
Turkey Medical Park Gaziantep Hospital Gaziantep

Sponsors (1)

Lead Sponsor Collaborator
Medical Park Gaziantep Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary cyst recurrence 24 months Yes
Secondary mortality 24 months Yes
Secondary intraoperative complications 24 hours Yes
Secondary late complications 24 months Yes
Secondary pain score VAS scoring scale will be use Post opertaive 6th hour, 1, 2, and 7th days Yes
Secondary patient comfort/satisfaction will be measured in all follow-up examinations using a scale from 0 (worst) to 10 (excellent). 24 months No
Secondary hospital stay postoperative hospital days 10 days No
Secondary duration of the operation from incision to closure of the skin 240 minutes No
Secondary quality of life first week, 1, 6, 12, and 24 month after operation No
See also
  Status Clinical Trial Phase
Recruiting NCT06316154 - Presentation of Protoscolexes and Acephalocysts in the Fibrous Capsule Area of the Liver With Echinococcosis
Completed NCT01785212 - The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver N/A
Completed NCT05420155 - Surgical Treatment of Liver Hydatid Cyst (SURGHIDA)
Recruiting NCT05090020 - Hypernatremia in Hydatid Cyst Treatment

External Links